14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Toward a More Accurate Estimate of the Prevalence of Hepatitis C in the United States

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Data from the 2003-2010 National Health and Nutrition Examination Survey (NHANES) indicate that about 3.6 million people in the United States have antibodies to the hepatitis C virus, of whom 2.7 million are currently infected. NHANES, however, excludes several high-risk populations from its sampling frame, including people who are incarcerated, homeless, or hospitalized; nursing home residents; active-duty military personnel; and people living on Indian reservations. We undertook a systematic review of peer-reviewed literature and sought out unpublished presentations and data to estimate the prevalence of hepatitis C in these excluded populations and in turn improve the estimate of the number of people with hepatitis C in the United States. The available data do not support a precise result, but we estimated that 1.0 million (range 0.4 million-1.8 million) persons excluded from the NHANES sampling frame have hepatitis C virus antibody, including 500,000 incarcerated people, 220,000 homeless people, 120,000 people living on Indian reservations, and 75,000 people in hospitals. Most are men. An estimated 0.8 million (range 0.3 million-1.5 million) are currently infected. Several additional sources of underestimation, including nonresponse bias and the underrepresentation of other groups at increased risk of hepatitis C that are not excluded from the NHANES sampling frame, were not addressed in this study.

          Conclusion

          The number of US residents who have been infected with hepatitis C is unknown but is probably at least 4.6 million (range 3.4 million-6.0 million), and of these, at least 3.5 million (range 2.5 million-4.7 million) are currently infected; additional sources of potential underestimation suggest that the true prevalence could well be higher.

          Related collections

          Author and article information

          Journal
          8302946
          4093
          Hepatology
          Hepatology
          Hepatology (Baltimore, Md.)
          0270-9139
          1527-3350
          4 February 2016
          25 August 2015
          November 2015
          01 November 2016
          : 62
          : 5
          : 1353-1363
          Affiliations
          [1 ]Department of Medicine, Weill Cornell Medical College, New York, NY
          [2 ]Institute for Infectious Disease Research, National Development and Research Institutes, New York, NY
          [3 ]Department of Psychiatry, Beth Israel Medical Center, New York, NY
          [4 ]Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA
          [5 ]Treatment Action Group, New York, NY
          Author notes
          Address reprint requests to: Brian R. Edlin, M.D., 71 West 23rd St., 4th floor, New York, NY 10010. bredlin.nyc@ 123456gmail.com ; tel: +1-212-845-4477; fax: +1-888-314-9637 or +1-212-845-4600.
          Article
          PMC4751870 PMC4751870 4751870 nihpa756518
          10.1002/hep.27978
          4751870
          26171595
          5f0afd5f-4595-4b45-9dda-fd01ef82305e
          History
          Categories
          Article

          Comments

          Comment on this article